Exploring the Preventive Potential of Solubilized Sturgeon Oil on Acute Infection with Respiratory Viruses.

Acute respiratory viral infections (ARIs) represent a significant global health challenge, contributing heavily to worldwide morbidity and mortality rates. Recent efforts to combat ARIs have focused on developing nasal spray formulations that effectively target the nasal mucosa. However, challenges...

Full description

Bibliographic Details
Published in:Marine Drugs
Main Authors: Park, Seong Ok, Uyangaa, Erdenebileg, Lee, Yong-Kwang, Yun, Suk-Hyun, Yu, Minyeong, Kim, Hyo Jin, Cho, Hye Won, Byeon, Hee Won, Lee, Chong-Kil, Eo, Seong Kug
Format: Article in Journal/Newspaper
Language:English
Published: MDPI 2025
Subjects:
SARS-CoV-2
acute respiratory viral infection
influenza A virus
respiratory syncytial virus
solubilized sturgeon oil
Aris
Siberian sturgeon
Online Access:https://doi.org/10.3390/md23030112
https://pubmed.ncbi.nlm.nih.gov/40137298
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11943521/
Description
Summary:Acute respiratory viral infections (ARIs) represent a significant global health challenge, contributing heavily to worldwide morbidity and mortality rates. Recent efforts to combat ARIs have focused on developing nasal spray formulations that effectively target the nasal mucosa. However, challenges such as irritation, discomfort, and safety concerns highlight the need for natural, eco-friendly ingredients. In this study, we evaluated the efficacy of solubilized sturgeon oil (SSO), prepared as an oil-in-water nanoemulsion from Siberian sturgeon, as an eco-friendly preventive nasal spray agent against ARIs. Intranasal pre-treatment with SSO effectively inhibited respiratory infections caused by SARS-CoV-2, influenza A virus (IAV), and respiratory syncytial virus (RSV). Additionally, it suppressed viral replication in both nasal and lung tissues. This antiviral effect was linked to reduced pulmonary inflammation, characterized by decreased infiltration of Ly-6C+ monocytes and Ly-6G+ neutrophils, along with lower pro-inflammatory cytokine levels. Histopathological analyses confirmed that nasal SSO administration significantly mitigated lung inflammation progression caused by viral infections. Notably, the protective effects of SSO against SARS-CoV-2, IAV, and RSV persisted for at least six hours following nasal application. These findings highlight SSO as a promising eco-friendly and safe candidate for nasal spray formulations, providing a potential frontline defense against ARIs.

Similar Items